🕒 Monday 27 July 2026 Mon, 27 July 2026

Minerals Exploration Limited has completed its first phase of diamond drilling at the historic Jubilee Gold Mine within the Waitekauri Gold Project, confirming multiple quartz-mineralised zones and exceptional high-grade rock chip assays. Exploration continues with promising results at the Invincible Gold and Glenorchy Tungsten projects.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Yojee has transitioned its MOSAIC freight forwarding platform into commercial operations, securing multiple contracts including two long-term Everest Founding Partners and outlining a strategic AI-driven roadmap.

Valiant Gold has made significant progress toward restarting its Comet mine with dewatering underway and technical studies advancing, while maiden drilling at Reedy reveals gold mineralisation extending over 400 metres below the existing resource.

Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.

Santana Minerals has reported exceptional high-grade gold intercepts from infill drilling at its Rise and Shine orebody, including a standout 24.4m at 10.9 g/t Au and a deeper 2m section grading 89.5 g/t Au. These results enhance confidence in the deposit’s grade model and the upcoming mining schedule.

FBR Limited has partnered with Industrial Robotics LLC to distribute and support its Mantis™ welding robots across the United States and Canada, targeting key southern states and expanding its footprint without increasing headcount.

Strategic Energy Resources (ASX:SER) is gearing up for a major 2026 field season with three high-impact diamond drilling programs across its Queensland copper-gold projects, backed by joint ventures and government grants. A $1.5 million capital raise recently completed will support drilling activities, while a new $6 million JV with Sumitomo Metals Mining targets the Bulimba Gold Project.

Arika Resources has locked in $6.55 million through a placement led by Lion Selection Group, which will hold a 6.7% stake, to fund a major drilling campaign at its Yundamindra and Kookynie gold projects in Western Australia.

Tasman Resources (ASX:TAS) is gearing up for a significant ramp-up in drilling activity across its Lake Torrens and Parkinson Dam projects, with Fortescue (ASX:FMG) set to drill two maiden holes at the Titan West IOCG target starting late August 2026. Meanwhile, Tasman plans up to twenty new drill holes at Parkinson Dam targeting high-priority epithermal and hydrothermal prospects.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

Verbrec Limited confirms a robust FY2026 with revenues up nearly 50%, while unveiling a bullish FY2027 outlook driven by full-year Alliance Automation integration and expanding project pipelines.

West Wits Mining has achieved a major underground breakthrough at Qala Shallows, unlocking higher-grade ore zones, while completing a comprehensive ZAR 1.115 billion finance package that underpins its production ramp-up.

Noronex Ltd has secured a major foothold in the US critical minerals sector by acquiring the Sleitat Tin-Tungsten-Silver Project in Alaska, featuring a substantial historic tin estimate and promising exploration upside.

Biome Australia (ASX: BIO) edged close to breakeven in FY26, driven by $1.8 million in international sales across four markets and a 68% gross margin. The company is set to launch onshore manufacturing and a digital health platform to accelerate growth.

Alma Metals is advancing its Briggs Copper Project with ongoing infill drilling aimed at upgrading resources and has boosted its operational capacity by acquiring a new exploration camp. The company completed a $4 million placement, strengthening its balance sheet as it pushes toward a Pre-Feasibility Study.

Critical Resources (ASX:CRR) spotlighted its multi-commodity pipeline and breakthrough battery cooling technology at the July 2026 TechKnow Invest Roadshow, highlighting exploration progress and exclusive global licensing deals.

AML3D Limited closed FY26 with a record $29 million order book, driven by US defence contracts and a $12 million investment to double its Ohio manufacturing capacity. The company’s cash receipts rose 20% to $10.4 million, while its sales pipeline expanded to $78 million.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.

Electro Optic Systems (ASX:EOS) posted a 284% surge in first-half 2026 revenue to $169 million, driven by robust defence contracts and regional tensions. Its order book hit a historic $846 million, prompting an upgrade to full-year guidance and signalling strong momentum in counter-drone and laser weapon systems.

Anax Metals has kicked off Front-End Engineering Design for its Whim Creek Copper Project, setting the stage for a Final Investment Decision by the end of 2026. The project, boasting a robust DFS with a pre-tax NPV7 of A$501 million and a 98% IRR, moves closer to construction amid ongoing financing talks.

Critica Limited’s recent drilling at the Juno satellite deposit within the Brothers Rare Earth Project has revealed multiple shallow, high-grade rare earth intersections across a 45 km2 area, reinforcing the project’s growth potential and metallurgical compatibility with the flagship Jupiter deposit.

Dexus has completed the sale of three office properties for $715 million, surpassing its $2 billion divestment target ahead of schedule. The transactions reinforce its disciplined capital management and will reduce gearing by around 2 percentage points.

EQT AB’s controlled entity has raised its indicative offer for Perpetual to A$22.50 per share, a modest increase contingent on the sale of Perpetual’s Wealth Management business and other conditions. The Perpetual Board remains undecided and has not recommended shareholder action.